ANGLE plc (ANPCF)
USD 0.16
(0.0%)
USD 0.16
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -21.75 Million GBP | 17.47% |
| 2022 | -24.2 Million GBP | -40.45% |
| 2021 | -17.23 Million GBP | -25.52% |
| 2020 | -13.73 Million GBP | -4.47% |
| 2019 | -13.14 Million GBP | -20.59% |
| 2018 | -10.89 Million GBP | -22.01% |
| 2017 | -8.93 Million GBP | -20.15% |
| 2016 | -7.43 Million GBP | -36.45% |
| 2015 | -5.44 Million GBP | -40.51% |
| 2014 | -3.87 Million GBP | -187.26% |
| 2013 | -1.35 Million GBP | -25.92% |
| 2012 | -1.07 Million GBP | 61.01% |
| 2011 | -2.75 Million GBP | -982.68% |
| 2010 | -254 Thousand GBP | -443.24% |
| 2009 | 74 Thousand GBP | 102.19% |
| 2008 | -3.37 Million GBP | -410.28% |
| 2007 | 1.08 Million GBP | 111.46% |
| 2006 | -9.5 Million GBP | -239.5% |
| 2005 | -2.8 Million GBP | 0.0% |
| 2004 | -2.8 Million GBP | -222.7% |
| 2003 | 2.28 Million GBP | 741.01% |
| 2002 | -356 Thousand GBP | 68.27% |
| 2001 | -1.12 Million GBP | 8.26% |
| 2000 | -1.22 Million GBP | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -4.15 Million GBP | 25.37% |
| 2024 Q2 | -4.15 Million GBP | 0.0% |
| 2023 Q1 | -5.31 Million GBP | 61.59% |
| 2023 Q3 | -4.59 Million GBP | 56.81% |
| 2023 Q4 | -5.56 Million GBP | -21.11% |
| 2023 FY | -19.97 Million GBP | 17.47% |
| 2023 Q2 | -10.63 Million GBP | -100.0% |
| 2022 Q4 | -13.84 Million GBP | -83.09% |
| 2022 Q2 | -10.36 Million GBP | -100.0% |
| 2022 Q1 | -5.18 Million GBP | 39.72% |
| 2022 FY | -24.2 Million GBP | -40.45% |
| 2022 Q3 | -7.55 Million GBP | 27.07% |
| 2021 Q1 | -4.33 Million GBP | 45.7% |
| 2021 Q4 | -8.59 Million GBP | -113.06% |
| 2021 Q2 | -8.66 Million GBP | -100.0% |
| 2021 FY | -17.23 Million GBP | -25.52% |
| 2021 Q3 | -4.03 Million GBP | 53.41% |
| 2020 Q2 | -5.77 Million GBP | -160.55% |
| 2020 Q1 | -2.21 Million GBP | 0.0% |
| 2020 FY | -13.73 Million GBP | -4.47% |
| 2020 Q3 | -4.09 Million GBP | 29.21% |
| 2020 Q4 | -7.97 Million GBP | -94.96% |
| 2019 Q1 | -2.65 Million GBP | 0.0% |
| 2019 FY | -13.14 Million GBP | -20.59% |
| 2019 Q2 | -3.04 Million GBP | -14.98% |
| 2018 Q3 | -5.03 Million GBP | 0.0% |
| 2018 Q1 | -4.82 Million GBP | -120.99% |
| 2018 Q4 | -2.65 Million GBP | 47.41% |
| 2018 FY | -10.89 Million GBP | -22.01% |
| 2017 Q2 | -2.05 Million GBP | 0.0% |
| 2017 Q4 | -2.18 Million GBP | -6.15% |
| 2017 Q3 | -2.05 Million GBP | 0.0% |
| 2017 FY | -8.93 Million GBP | -20.15% |
| 2016 Q1 | -1.49 Million GBP | 0.0% |
| 2016 Q3 | -1.45 Million GBP | 0.0% |
| 2016 Q2 | -1.45 Million GBP | 2.61% |
| 2016 FY | -7.43 Million GBP | -36.45% |
| 2015 FY | -5.44 Million GBP | -40.51% |
| 2015 Q1 | -1.1 Million GBP | 0.0% |
| 2015 Q2 | -1.19 Million GBP | -8.75% |
| 2015 Q3 | -1.19 Million GBP | 0.0% |
| 2015 Q4 | -1.49 Million GBP | -24.64% |
| 2014 Q1 | -1.34 Million GBP | -327.91% |
| 2014 Q4 | -1.1 Million GBP | -39.8% |
| 2014 Q3 | -789 Thousand GBP | 0.0% |
| 2014 FY | -3.87 Million GBP | -187.26% |
| 2014 Q2 | -789 Thousand GBP | 41.19% |
| 2013 Q2 | -278 Thousand GBP | -111.41% |
| 2013 Q3 | -278 Thousand GBP | 0.0% |
| 2013 FY | -1.35 Million GBP | -25.92% |
| 2013 Q1 | -131.5 Thousand GBP | 0.0% |
| 2013 Q4 | -313.5 Thousand GBP | -12.77% |
| 2012 Q4 | -131.5 Thousand GBP | 26.33% |
| 2012 FY | -1.07 Million GBP | 61.01% |
| 2012 Q2 | -178.5 Thousand GBP | 0.0% |
| 2012 Q3 | -178.5 Thousand GBP | 0.0% |
| 2011 FY | -2.75 Million GBP | -982.68% |
| 2010 FY | -254 Thousand GBP | -443.24% |
| 2009 FY | 74 Thousand GBP | 102.19% |
| 2008 FY | -3.37 Million GBP | -410.28% |
| 2007 FY | 1.08 Million GBP | 111.46% |
| 2006 FY | -9.5 Million GBP | -239.5% |
| 2005 FY | -2.8 Million GBP | 0.0% |
| 2004 FY | -2.8 Million GBP | -222.7% |
| 2003 FY | 2.28 Million GBP | 741.01% |
| 2002 FY | -356 Thousand GBP | 68.27% |
| 2001 FY | -1.12 Million GBP | 8.26% |
| 2000 FY | -1.22 Million GBP | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.24 Million USD | -1651.932% |
| Arrayit Corporation | -3.62 Million USD | -500.66% |
| Atlantic International Corp. | -5.73 Million USD | -279.572% |
| Biocept, Inc. | -31.98 Million USD | 31.967% |
| Bioqual, Inc. | -19.63 Thousand USD | -110700.489% |
| CardioGenics Holdings Inc | -772.14 Thousand USD | -2718.005% |
| DermTech, Inc. | -103.73 Million USD | 79.025% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.48 Billion USD | 100.875% |
| HTG Molecular Diagnostics, Inc. | -20.82 Million USD | -4.462% |
| iMD Companies, Inc. | -175.44 Thousand USD | -12302.107% |
| IDenta Corp. | -1499.00 USD | -1451467.712% |
| Interpace Biosciences, Inc. | 2.8 Million USD | 875.999% |
| Integrative Health Technologies, Inc. | 38.69 Thousand USD | 56339.338% |
| InVitro International | -25.33 Thousand USD | -85771.581% |
| Lumos Diagnostics Holdings Limited | -7.12 Million USD | -205.518% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | -37343.213% |
| Medical Imaging Corp. | -819.48 Thousand USD | -2555.22% |
| NovelStem International Corp. | -3.52 Million USD | -517.137% |
| Optigenex Inc. | 1.39 Million USD | 1664.456% |
| PharmChem, Inc. | 973.14 Thousand USD | 2335.942% |
| Proteome Sciences plc | -1.62 Million USD | -1242.32% |
| Response Genetics, Inc | -21.37 Million USD | -1.787% |
| Rennova Health, Inc. | -1.4 Million USD | -1443.702% |
| RushNet, Inc. | -684.7 Thousand USD | -3077.865% |
| ScreenPro Security Inc. | -2.59 Million USD | -739.329% |
| Stella Diagnostics Inc. | -11.42 Million USD | -90.418% |
| StageZero Life Sciences Ltd. | -7.74 Million USD | -180.879% |
| Todos Medical Ltd. | -9.74 Million USD | -123.215% |